ABBV - Abbvie
This page shows which of the focused investors we track hold ABBV and how their positions changed, so you can see how much conviction the group has in the stock.
In Q2 2026 it was held by 7 managers with an aggregate reported value of $51M, which is 0.00% of the combined portfolio.
As of Q2 2026, 7 tracked institutional managers held ABBV (Abbvie) with an aggregate reported value of $51M — 0.00% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades ABBV — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q2 2026
- Ticker
- ABBV
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Torray Funds - Torray Funds | 2.80% | Reduce -11.7% | 82,602 | $20.79M |
| 2 | Mairs & Power Growth Fund - Mairs & Power Growth Fund | 0.10% | Reduce -1.4% | 44,702 | $11.25M |
| 3 | David Katz - Matrix Asset Advisors | 0.80% | Reduce -0.3% | 39,070 | $9.83M |
| 4 | Thomas Russo - Gardner Russo & Quinn | 0.04% | - | 12,410 | $3.12M |
| 5 | Jensen Investment Management - Jensen Investment Management | 0.07% | Reduce -0.7% | 11,064 | $2.78M |
| 6 | Dodge & Cox - Dodge & Cox | 0.00% | - | 10,393 | $2.62M |
| 7 | Bill Nygren - Oakmark Funds | 0.00% | Reduce -9.8% | 2,420 | $608.97K |
Loading holder history for ABBV…